LEMAITRE VASCULAR INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M |
| Gross profit | $178.5M | $150.9M | $127.0M | $104.9M | $101.4M |
| Operating income | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M |
| Operating expenses | $110.6M | $98.6M | $90.3M | $78.1M | $65.0M |
| Cost of revenue | $71.1M | $69.0M | $66.4M | $56.8M | $53.0M |
| Cash from operations | $81.3M | $44.1M | $36.8M | $25.4M | $35.1M |
| Capital expenditure | $6.8M | $7.0M | $7.3M | $3.2M | $4.9M |
| Free cash flow | $74.5M | $37.2M | $29.5M | $22.1M | $30.2M |
| Share repurchases | $1.8M | $1.7M | $853,000 | $642,000 | $802,000 |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $615.7M | $551.8M | $346.8M | $310.5M | $292.8M |
| Total liabilities | $222.2M | $214.5M | $48.9M | $42.3M | $38.7M |
Shares outstanding 22.9M · Free float 92.6%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.